Tu1544 CLINICAL BENEFITS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE IN A CONTEMPORARY COHORT OF AT-RISK PATIENTS
Leggi →
Maggio 2024
Risultati per: Carcinoma della prostata
Questo è quello che abbiamo trovato per te
Tu1545 CLINICAL SIGNIFICANCE OF SERUM C-REACTIVE PROTEIN LEVELS FOR PREDICTING LENVATINIB-TREATED UNRESECTABLE HEPATOCELLULAR CARCINOMA: A MULTI-INSTITUTIONAL STUDY IN JAPAN
Leggi →
Maggio 2024
Su1571 METFORMIN-MEDIATED ENHANCEMENT OF HEPATOCELLULAR CARCINOMA PROGNOSIS THROUGH IL33: INSIGHTS FROM TRANSCRIPTOME ANALYSIS
Leggi →
Maggio 2024
Tu1558 MODIFIED MELD 3.0 SARCOPENIA SCORES IMPROVE PREDICTIVE ACCURACY FOR OVERALL SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING LOCOREGIONAL THERAPY.
Leggi →
Maggio 2024
Mo1248 DEVELOPMENT OF PANEL OF THREE-DIMENSIONAL BIOMARKERS TO IDENTIFY GASTRIC CARCINOMA AND PRECANCEROUS LESIONS OF THE STOMACH – AN ANALYTICAL CROSS-SECTIONAL STUDY
Leggi →
Maggio 2024
Tu1555 IMMUNOTHERAPY VERSUS LENVATINIB IN ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTER, NATIONWIDE PROPENSITY SCORE MATCHING ANALYSIS
Leggi →
Maggio 2024
Tu1534 MULTICENTER COMPARISON OF ABBREVIATED MRI VERSUS ULTRASOUND FOR DETECTING EARLY-STAGE HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS
Leggi →
Maggio 2024
Tu1571 ANALYZING THE TRENDS AND GENDER DISPARITIES IN HEPATITIS CRELATED HEPATOCELLULAR CARCINOMA MORTALITY RATES IN WORLD BANK REGIONS USING THE GLOBAL BURDEN OF DISEASE DATABASE FROM 1999 TO 2019
Leggi →
Maggio 2024
Tu1550 COMBINATION IRREVERSIBLE ELECTROPORATION AND ANTI-PD1 THERAPY REVERSES MDSC INDUCED IMMUNE-SUPPRESSIVE MICROENVIRONMENT IN HEPATOCELLULAR CARCINOMA.
Leggi →
Maggio 2024
Sa1526 CATENIBACTERIUM MITSUOKAI PROMOTES TUMOR IMMUNOSUPPRESSION THROUGH METABOLIC REPROGRAMMING OF PMN-MDSC IN HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
91 A CIRCRNA BASED-LIQUID BIOPSY FOR NONINVASIVE AND EARLY DETECTION OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Leggi →
Maggio 2024
Tu1559 RISK OF HEPATOCELLULAR CARCINOMA AMONGST SUBCENTIMETER NODULES ON SURVEILLANCE ULTRASOUND: A SYSTEMATIC REVIEW
Leggi →
Maggio 2024
Tu1543 RURALITY OF RESIDENCE AND DISPARITY IN INCIDENT HEPATOCELLULAR CARCINOMA AMONG VIETNAM WAR VETERANS
Leggi →
Maggio 2024
Tu1562 ASSESSING ATEZOLIZUMAB PLUS BEVACIZUMAB TREATMENT FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS WITH ESOPHAGEAL-GASTRIC VARICES
Leggi →
Maggio 2024
Tu1538 RISK OF BILIARY STRICTURES AFTER RADIATION THERAPY FOR HEPATOCELLULAR CARCINOMA (HCC)
Leggi →
Maggio 2024
Tu1535 DEVELOPMENT OF ABDOMINAL VARICES IS ASSOCIATED WITH INCREASED HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH ADVANCED FIBROSIS AND CIRRHOSIS
Leggi →
Maggio 2024
